Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Market Outlook Novo Nordisk A/S China Markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Investment strategy Novo Nordisk A/S Meta Platforms Inc
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Obesity Transportation and shipping Drugs
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Strikes Transportation Infrastructure US Economy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Eli Lilly and Co Science Health & Science
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags Economy Investment strategy Technology
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Healthy Returns Social issues GSK plc
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Companies Business US: News
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags Williams Companies Inc Taylor Morrison Home Corp Entergy Corp
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags General NVO Health Care
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags CVS Health Corp Sanofi SA US: News
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Inflation Earnings Amazon/com Inc
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Jobs Interest Rates Roche Holding AG
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Healthy Returns Social issues Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Markets Investing Novo Nordisk A/S
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Eli Lilly and Co Novo Nordisk A/S Markets
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags US: News Business Companies
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Breaking news Companies Business
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Biotech and Pharmaceuticals Health & Science US: News
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Business News Breaking News: Business Biotechnology
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Companies Breaking news US: News
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Pharmaceuticals Health care industry Novo Nordisk A/S
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Companies US: News Business
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Viking Therapeutics Inc Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.